Your browser doesn't support javascript.
loading
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force.
Bridges, John F P; de Bekker-Grob, Esther W; Hauber, Brett; Heidenreich, Sebastian; Janssen, Ellen; Bast, Alice; Hanmer, Janel; Danyliv, Andriy; Low, Eric; Bouvy, Jacoline C; Marshall, Deborah A.
Afiliación
  • Bridges JFP; The Ohio State University College of Medicine, Columbus, OH, USA. Electronic address: John.Bridges@osumc.edu.
  • de Bekker-Grob EW; Erasmus University Rotterdam, Rotterdam, the Netherlands.
  • Hauber B; Pfizer, Inc, New York, NY, USA.
  • Heidenreich S; Evidera, London, England, UK.
  • Janssen E; Janssen Research & Development, LLC, New Brunswick, NJ, USA.
  • Bast A; Beyond Celiac, Ambler, PA, USA.
  • Hanmer J; University of Pittsburgh, Pittsburgh, PA, USA.
  • Danyliv A; Novartis Pharma AG, Basel, Switzerland.
  • Low E; Eric Low Consulting, Haddington, Scotland, UK.
  • Bouvy JC; NICE, London, England, UK.
  • Marshall DA; University of Calgary, Calgary, AB, Canada.
Value Health ; 26(2): 153-162, 2023 02.
Article en En | MEDLINE | ID: mdl-36754539
ABSTRACT
Many qualitative and quantitative methods are readily available to study patient preferences in health. These methods are now being used to inform a wide variety of decisions, and there is a growing body of evidence showing studies of patient preferences can be used for decision making in a wide variety of contexts. This ISPOR Task Force report synthesizes current good practices for increasing the usefulness and impact of patient-preference studies in decision making. We provide the ISPOR Roadmap for Patient Preferences in Decision Making that invites patient-preference researchers to work with decision makers, patients and patient groups, and other stakeholders to ensure that studies are useful and impactful. The ISPOR Roadmap consists of 5 key elements (1) context, (2) purpose, (3) population, (4) method, and (5) impact. In this report, we define these 5 elements and provide good practices on how patient-preference researchers and others can actively contribute to increasing the usefulness and impact of patient-preference studies in decision making. We also present a set of key questions that can support researchers and other stakeholders (eg, funders, reviewers, readers) to assess efforts that promote the ongoing impact (both intended and unintended) of a particular preference study and additional studies in the future.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Comités Consultivos / Prioridad del Paciente Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Comités Consultivos / Prioridad del Paciente Tipo de estudio: Prognostic_studies / Qualitative_research Límite: Humans Idioma: En Revista: Value Health Asunto de la revista: FARMACOLOGIA Año: 2023 Tipo del documento: Article